Context Therapeutics Inc. (CNTX)
NASDAQ: CNTX · Real-Time Price · USD
0.45905
-0.0067 (-1.45%)
Aug 12, 2026, 11:06 AM EDT - Market open

Context Therapeutics Financials Overview

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Income
-48.73-39.7-29.92-25.07-15.38-10.53
Net Income
-45.96-36.12-26.73-23.96-14.84-10.46
Earnings Per Share
-0.48-0.38-0.46-1.50-0.93-3.69
EPS Growth
------

Cash & Debt

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
42.996694.4314.4535.549.64
Total Debt
0.240.110.2200.060
Net Cash (Debt)
42.7565.8894.2114.4535.4449.64
Net Cash Growth
-48.72%-30.07%551.98%-59.23%-28.59%-
Net Cash Per Share
0.450.691.610.912.2217.52

Cash Flow & CapEx

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
-33.97-26.39-14.56-21.05-13.55-8.8
Capital Expenditures
-0.06-0.03-0.01--0.04-
Free Cash Flow
-34.03-26.42-14.56-21.05-13.59-8.8
Free Cash Flow Growth
------

Valuation

Selected indicators aren't available for this stock.